EU pre-registration deadline for phase-in chemicals nears
This article was originally published in SRA
Companies subject to the REACH chemicals legislation in the European Union – including medtech manufacturers – have until 30 November to pre-register certain “phase-in” chemical substances with the European Chemicals Agency (ECHA)1. The same registration deadline applies to high-volume manufacturers and importers. The ECHA has published this reminder, as well as a number of other announcements, in the past month.
You may also be interested in...
The two-year results from the PARTNER 3 trial showed transcatheter aortic valve replacement with Edwards Lifesciences' Sapien 3 system was statistically non-inferior to surgical valve replacement in low-risk patients. The one-year results from the trial had shown TAVR was superior to surgery in low-risk patients.
Experience and data from the study, which will use the same vector platform to deliver different transgenes for different diseases, could feed into the US FDA’s efforts to establish a public-private partnership to enable manufacturing of gene therapies for ultra-rare diseases.
Non-Hygiene Personal Care ‘Essential’ In California … For Now; COVID-19 Event Impacts; Cosmetics News In Brief
Santa Monica, CA-based law firm Conkle, Kremer and Engle warns that while all personal-care product businesses appear to be designated “essential” in the Golden State under its statewide “stay at home” order, officials could decide that the policy does not apply to manufacturers of non-hygiene products. More cosmetics news in brief.